Evidence map›Paper›PMID 39285247›Full record

ReviewEMBO reports2024

Amplified centrosomes-more than just a threat.

Eva Kiermaier, Isabel Stötzel, Marina A Schapfl, Andreas Villunger

Abstract readReview
In one paragraph

Review in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Ciliary and Non-Ciliary Roles of IFT88 in Development and Diseases.International journal of molecular sciences · 2025
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eva KiermaierLife and Medical Sciences Institute, Immune and Tumor Biology, University of Bonn, Bonn, Germany. ekiermai@uni-bonn.de.ORCID 0000-0001-6165-5738
Isabel StötzelLife and Medical Sciences Institute, Immune and Tumor Biology, University of Bonn, Bonn, Germany.ORCID 0000-0001-6326-1409
Marina A SchapflInstitute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3764-9615
Andreas VillungerInstitute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria. andreas.villunger@i-med.ac.at.ORCID 0000-0001-8259-4153

Funding

Austrian Science Fund (FWF) DOC82Austrian Science Fund (FWF) I 6642Austrian Science Fund (FWF) P 36658Deutsche Forschungsgemeinschaft (DFG) EXC 2151 - 390873048EC | European Research Council (ERC) ERC_AdG 787171Ministry of Innovation, Science and Research of North-Rhine-Westphalia 421-8.03.03.02-137069
6 · The paper itself

Abstract

Centrosomes are major organizing components of the tubulin-based cytoskeleton. In recent years, we have gained extensive knowledge about their structure, biogenesis, and function from single cells, cell-cell interactions to tissue homeostasis, including their role in human diseases. Centrosome abnormalities are linked to, among others primary microcephaly, birth defects, ciliopathies, and tumorigenesis. Centrosome amplification, a state where two or more centrosomes are present in the G1 phase of the cell cycle, correlates in cancer with karyotype alterations, clinical aggressiveness, and lymph node metastasis. However, amplified centrosomes also appear in healthy tissues and, independent of their established role, in multi-ciliation. One example is the liver where hepatocytes carry amplified centrosomes owing to whole-genome duplication events during organogenesis. More recently, amplified centrosomes have been found in neuronal progenitors and several cell types of hematopoietic origin in which they enhance cellular effector functions. These findings suggest that extra centrosomes do not necessarily pose a risk for genome integrity and are harnessed for physiological processes. Here, we compare established and emerging 'non-canonical functions' of amplified centrosomes in cancerous and somatic cells and discuss their role in cellular physiology.

Indexed as

CentrosomeNeoplasmsAnimalsHumansCancerCentrosomesDifferentiationImmunityMigration

Identifiers

PMID39285247
PMCPMC11467336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.